Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

20 ML Albumin Human, USP 250 MG/ML Injection [Albutein]

Known as: Albumin Human 12.5 g in 50 mL INTRAVENOUS INJECTION, SOLUTION [ALBUTEIN]_#3, Albutein 25 % per 20 ML Injection, Albutein 250 MG/ML per 20 ML Injection 
 
National Institutes of Health

Related topics

Related topics

7 relations
Albumin Human, USPAlbuteinInjectionSODIUM ACETYLTRYPTOPHANATE
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer…
INTRODUCTION There is a growing interest in new therapeutic strategies for the treatment of Alzheimer disease (AD) which focus on… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2016
Review
2016
Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer…
Abstract Introduction There is a growing interest in new therapeutic strategies for the treatment of Alzheimer disease (AD) which… Expand
Is this relevant?
2012
2012
Therapeutic albumin binding to remove amyloid-β.
Clearance of plasma amyloid-β (Aβ) through plasma exchange and replacement with therapeutic albumin to facilitate net Aβ efflux… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE